Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg $36
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg $143
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  2. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  3. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  4. Zaman R, et al. 2021. Immunity. :. PubMed
  5. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  6. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  7. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  8. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  9. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  10. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  11. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  12. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  13. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  14. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  15. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  16. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  17. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  18. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  19. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  20. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  21. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  22. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  23. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  24. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  25. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  26. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  27. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  28. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  29. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  30. Kim HI, et al. 2022. Molecules. 27: . PubMed
  31. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  32. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  33. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  34. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  35. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  36. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  37. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  38. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  39. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  40. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  41. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  42. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  43. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  44. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  45. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  46. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  47. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  48. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  49. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  50. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  51. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  52. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  53. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  54. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  55. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  56. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  57. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  58. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  59. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  60. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  61. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  62. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  63. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  64. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  65. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  66. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  67. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  68. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  69. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  70. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  71. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  72. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  73. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  74. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  75. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  76. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  77. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  78. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  79. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  80. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  81. Gawish R, et al. 2022. Elife. 11:. PubMed
  82. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  83. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  84. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  85. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  86. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  87. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  88. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  89. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  90. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  91. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  92. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  93. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  94. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  95. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  96. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  97. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  98. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  99. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  100. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  101. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  102. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  103. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  104. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  105. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  106. Diao L, et al. 2022. iScience. 25:105511. PubMed
  107. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  108. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  109. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  110. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  111. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  112. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  113. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  114. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  115. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  116. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  117. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  118. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  119. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  120. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  121. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  122. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  123. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  124. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  125. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  126. White C, et al. 2014. J Immunol. 193:5933. PubMed
  127. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  128. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  129. Deng P, et al. 2022. Cells. 11:. PubMed
  130. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  131. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  132. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  133. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  134. Solanki A, et al. 2018. Development. 145. PubMed
  135. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  136. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  137. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  138. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  139. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  140. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  141. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  142. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  143. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  144. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  145. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  146. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  147. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  148. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  149. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  150. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  151. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  152. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  153. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  154. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  155. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  156. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  157. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  158. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  159. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  160. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  161. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  162. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  163. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  164. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  165. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  166. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  167. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  168. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  169. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  170. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  171. Xu X, et al. 2018. Cell. 175:1336. PubMed
  172. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  173. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  174. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  175. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  176. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  177. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  178. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  179. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  180. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  181. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  182. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  183. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  184. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  185. França TT, et al. 2021. JCI Insight. 6:. PubMed
  186. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  187. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  188. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  189. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  190. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  191. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  192. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  193. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  194. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  195. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  196. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  197. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  198. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  199. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  200. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  201. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  202. Port JR, et al. 2020. J Virol. 94:. PubMed
  203. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  204. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  205. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  206. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  207. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  208. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  209. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  210. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  211. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  212. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  213. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  214. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  215. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  216. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  217. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  218. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  219. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  220. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  221. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  222. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  223. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  224. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  225. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  226. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  227. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  228. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  229. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  230. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  231. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  232. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  233. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  234. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  235. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  236. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  237. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  238. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  239. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  240. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  241. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  242. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  243. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  244. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  245. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  246. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  247. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  248. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  249. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  250. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  251. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  252. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  253. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  254. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  255. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  256. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  257. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  258. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  259. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  260. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  261. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  262. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  263. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  264. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  265. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  266. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  267. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  268. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  269. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  270. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  271. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  272. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  273. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  274. Tao Z, et al. 2022. Cells. 11:. PubMed
  275. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  276. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  277. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  278. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  279. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  280. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  281. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  282. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  283. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  284. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  285. Zheng Y, et al. 2022. Transl Res. :. PubMed
  286. Gawish R, et al. 2022. Elife. 11:. PubMed
  287. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  288. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  289. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  290. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  291. Li J, et al. 2021. eLife. 10:00. PubMed
  292. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  293. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  294. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  295. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  296. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  297. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  298. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  299. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  300. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  301. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  302. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  303. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  304. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account